Squarepoint’s Insmed INSM Stock Holding History

Squarepoint’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Sell	2,900 -5,700	-66%	-$690K	﹤0.01%	3781
2026 Q1	$1.41M	Buy	+8,600	New	+$1.32M	﹤0.01%	2471
2025 Q4	–	Sell	-45,500	Closed	-$6.55M	–	4555
2025 Q3	$6.55M	Hold	45,500	–	–	0.01%	1306
2025 Q2	$4.58M	Buy	+45,500	New	+$3.48M	﹤0.01%	1518

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Squarepoint's INSM Position: Q2 2026 in Review

Squarepoint increased its Insmed (INSM) stake by 1,468% in Q2 2026, buying an estimated $69.9M and bringing the position to 616,464 shares worth $65.7M. The position accounts for 0.07% of the portfolio, ranked #264.

Squarepoint first reported a position in INSM in Q4 2015 and has held it in 27 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Squarepoint held 616,464 shares of Insmed worth $65.7M as of Q2 2026.
Squarepoint bought 577,148 Insmed shares in Q2 2026, an estimated $69.9M.
Insmed made up 0.07% of Squarepoint's portfolio in Q2 2026, its #264 holding.
Squarepoint first reported a position in Insmed in Q4 2015 and has held it in 27 quarters since.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.